MM_Hub: CONGRESS|#EHA2021|@ThierryFacon, Lille University Hospital, presented poster on Phase3 IKEMA trial. It was identified that addition of Isatuximab to carfilzomib & dexamethasone improved PFS & quality of response in elderly pts, with a manageable safety profile #mmsm #myeloma

by | Jun 17, 2021 | Twitter

CONGRESS|#EHA2021|@ThierryFacon, Lille University Hospital, presented poster on Phase3 IKEMA trial. It was identified that addition of Isatuximab to carfilzomib & dexamethasone improved PFS & quality of response in elderly pts, with a manageable safety profile...

VincentRK: The 12th Annual International Myeloma Working Group (IMWG) Summit starts next week. ~100 myeloma experts will participate virtually on new treatment guidelines & research projects. @IMFmyeloma @BrianDurieMD Dr. Munshi and Dr. Kumar will be honored. @DanaFarber @MayoClinic

by | Jun 17, 2021 | Twitter

The 12th Annual International Myeloma Working Group (IMWG) Summit starts next week. ~100 myeloma experts will participate virtually on new treatment guidelines & research projects. @IMFmyeloma @BrianDurieMD Dr. Munshi and Dr. Kumar will be honored. @DanaFarber...

MM_Hub: CONGRESS|#EHA2021|@nickbolli, Universita Degli Studi di Milano emphasized upon genotyping potential to diagnose MGUS/SMM, to identify progression determinants, to provide better classification& prognostication of MM. More research is needed for clinical translation #mmsm #myeloma

by | Jun 17, 2021 | Twitter

CONGRESS|#EHA2021|@nickbolli, Universita Degli Studi di Milano emphasized upon genotyping potential to diagnose MGUS/SMM, to identify progression determinants, to provide better classification& prognostication of MM. More research is needed for clinical...

MM_Hub: CONGRESS|#EHA2021|@IreneGhobrial, @Mohty_EBMT discussed in an interactive session about factors, challenges in selecting therapy, optimization & pt management after 1st relapse in RRMM #mmsm #myeloma

by | Jun 16, 2021 | Twitter

CONGRESS|#EHA2021|@IreneGhobrial, @Mohty_EBMT discussed in an interactive session about factors, challenges in selecting therapy, optimization & pt management after 1st relapse in RRMM #mmsm #myeloma pic.twitter.com/GDAtCMTd3V— Multiple Myeloma Hub (@MM_Hub) June...